| Med. College of Georgia Research Institute, Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20100055111 | INDOLEAMINE 2,3-DIOXYGENASE, PD-1/PD-L PATHWAYS, AND CTLA4 PATHWAYS IN THE ACTIVATION OF REGULATORY T CELLS - The present invention includes methods of enhancing immune responses by administering an inhibitor of indoleamine-2,3-dioxygenase (IDO) along with one or more inhibitors of the PD-1/PD-L pathway and/or one or more inhibitors of the CTLA4 pathway. | 03-04-2010 |
| 20090215880 | Composition and Method for IN VIVO and IN VITRO Attenuation of Gene Expression Using Double Stranded RNA - Introduction of double stranded RNA into cells, cell culture, organs and tissues, and whole organisms, particularly vertebrates, specifically attenuates gene expression. | 08-27-2009 |
| 20090156520 | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA - Introduction of double stranded RNA into cells, cell culture, organs and tissues, and whole organisms, particularly vertebrates, specifically attenuates gene expression. | 06-18-2009 |
| 20090155311 | INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS - The present invention provides methods for the control of the generation of regulatory T cells (Tregs) and uses thereof. | 06-18-2009 |
